Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful

Presse Med. 2014 Mar;43(3):319-21. doi: 10.1016/j.lpm.2013.06.028. Epub 2014 Jan 20.

Authors

François Perrin¹, Antoine Néel², Julie Graveleau¹, Anne-Lise Ruellan³, Agathe Masseau¹, Mohamed Hamidou¹

Affiliations

¹ CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France.
² CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France. Electronic address: [email protected].
³ CHU Hôtel-Dieu, centre régional de pharmacovigilance, 44093 Nantes, France.

PMID: 24456697
DOI: 10.1016/j.lpm.2013.06.028

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antirheumatic Agents / adverse effects*
Humans
Interleukin 1 Receptor Antagonist Protein / administration & dosage
Interleukin 1 Receptor Antagonist Protein / adverse effects*
Male
Middle Aged
Neutropenia / chemically induced*
Neutropenia / drug therapy
Schnitzler Syndrome / drug therapy*
Still's Disease, Adult-Onset / drug therapy*

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein